Navigation Links
Tolerx Presents Baseline Data from DEFEND-1 Study Validating C-Peptide as Critical Clinical Measure for New-Onset Type 1 Diabetes
Date:6/28/2010

to 45, with newly diagnosed autoimmune type 1 diabetes. DEFEND-1 is being conducted at over 100 study centers throughout Europe and North America.  The study is designed to evaluate whether a single course of otelixizumab, administered not more than 90 days after the initial diagnosis of autoimmune type 1 diabetes, will preserve beta cell function as measured by C-peptide, a surrogate measure of beta cell function.  The primary endpoint is measurement of C-peptide.  For more information about DEFEND, please visit www.DefendAgainstDiabetes.com.

About Type 1 Diabetes

Diabetes (medically known as diabetes mellitus) is the name given to disorders in which the body has difficulty regulating its blood glucose (sugar) level.  There are two major types of diabetes:  type 1 and type 2. Type 1, previously known as juvenile diabetes or insulin-dependent diabetes, is a disorder involving the body's immune system.  In type 1 diabetes, the immune system attacks and destroys the insulin-producing beta cells in the pancreas.  As a result of the decrease in endogenous (natural) insulin production, patients must monitor their glucose levels frequently and administer insulin regularly to control their blood glucose levels. 

About Otelixizumab

Otelixizumab is a targeted T cell immunomodulator being developed for the treatment of type 1 diabetes and other autoimmune diseases.  Otelixizumab targets CD3, a T lymphocyte receptor involved in normal cell signaling.  Otelixizumab has not yet been approved for marketing. Data suggest that the anti
'/>"/>

SOURCE Tolerx, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Tolerx Presents Preclinical Data on Novel T-cell Modulator, TRX518, for Antitumor Immune Response at Federation of Clinical Immunology Societies Scientific Meeting
2. Tolerx Presents Data at 69th Scientific Sessions of the American Diabetes Association
3. Tolerx Initiates Dosing of Otelixizumab, a Novel Type 1 Diabetes Agent, in DEFEND, a Phase 3 Clinical Trial
4. Tolerx Announces Achievement of Milestones upon anti-CD4 Antibody Program Advancement and Initiation of Phase 1 Clinical Trial
5. Tolerx Advancing Novel Type 1 Diabetes Agent into Phase III Clinical Trial Program Following End of Phase II FDA Meeting
6. Tolerx Achieves Milestone with Completion of Phase Ib Clinical Study of TRX1 in Cutaneous Lupus Erythematosus
7. Lexicon Presents Data Describing LX4211 Positive Phase 2 Clinical Results and Novel Mechanism of Action for Type 2 Diabetes
8. Onyx Pharmaceuticals Presents Interim Results of Phase 1b Carfilzomib Combination Trial
9. Lilly Presents New Data in Advanced Melanoma - A Difficult-To-Treat Cancer That Causes Majority of Skin Cancer Deaths
10. Mpex Pharmaceuticals Presents Positive Phase 2 Clinical Trial Results of Aeroquin(TM) (MP-376) Treatment in Cystic Fibrosis Patients
11. Spectros Presents at the Pediatric Academic Societies (PAS) National Conference 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... EMERYVILLE, Calif. , Sept. 17, 2014 /PRNewswire/ ... newest data analytics solution that brings complete visibility ... minimize risks in an ever-evolving reimbursement landscape. Powered ... Integrity brings transparency to the critical point between ... operations impact revenue. The solution will improve revenue ...
(Date:9/17/2014)...   myMatrixx, a pharmacy and ancillary medical benefit manager ... magazine has awarded myMatrixx with a "Best Places to ... a row. Best Places to Work ... the Best Companies Group.  The competition, which involves months ... privately-held insurance industry companies with at least 25 employees ...
(Date:9/17/2014)... Women everywhere know how frustrating a vaginal ... they,re often also embarrassing and have a way of ... ( http://ph-defense.com ) is a new, over-the-counter product designed ... product. Odor, discharge, and discomfort or ... In many cases, the cause of such problems can ...
Breaking Medicine Technology:MedeAnalytics Unveils New Revenue Integrity Solution to Support the Transition to Value-Based Healthcare 2MedeAnalytics Unveils New Revenue Integrity Solution to Support the Transition to Value-Based Healthcare 3myMatrixx Honored with "Best Places to Work in Insurance" Award 2New Product from Vireo Systems: pH-D Feminine Health Support 2
... Trial for the Treatment of Pediatric Eosinophilic Esophagitis , ... Cephalon, Inc . (Nasdaq: CEPH ) and ... announced that the companies have signed an agreement providing ... stock of Ception. Under the terms of the ...
... of treatment, RAD001 halted tumor growth in 55% of ... Based on these promising data, Novartis will initiate a ... patients- Gastric cancer is the second leading cause of ... occurring in East AsiaEAST HANOVER, N.J., Jan. 13 ...
Cached Medicine Technology:Cephalon Signs Option Agreement to Acquire Ception Therapeutics 2Cephalon Signs Option Agreement to Acquire Ception Therapeutics 3Cephalon Signs Option Agreement to Acquire Ception Therapeutics 4RAD001 Phase II Trial Results Positive in Patients with Advanced Gastric Cancer After Failure of One or More Prior Treatments 2RAD001 Phase II Trial Results Positive in Patients with Advanced Gastric Cancer After Failure of One or More Prior Treatments 3RAD001 Phase II Trial Results Positive in Patients with Advanced Gastric Cancer After Failure of One or More Prior Treatments 4RAD001 Phase II Trial Results Positive in Patients with Advanced Gastric Cancer After Failure of One or More Prior Treatments 5RAD001 Phase II Trial Results Positive in Patients with Advanced Gastric Cancer After Failure of One or More Prior Treatments 6
(Date:9/17/2014)... UWDress.com, an innovative company that provides many kinds of ... its 2014 empire waist evening dress collection ... sale for these new and beautiful products. All of ... 15 to 65 percent off. , It is ... wear materials. Its elegant items include gold empire waist ...
(Date:9/17/2014)... 18, 2014 iFitDress.com, a renowned wedding dress ... petite evening dresses . All these outfits are now ... discounted shipping costs. , “iFitDress.com is a professional company ... We are now busy selling our new collection of petite ... an order above $800 can get free shipping. All these ...
(Date:9/17/2014)... Columbus, Ohio (PRWEB) September 18, 2014 ... cycle management services nationwide, announces today that they ... Fort Wayne Radiology (FWRadiology) in Fort Wayne, Indiana. ... range of billing services encompassing their proprietary suite ... Technology (EBT). EBT improves radiology billing and ...
(Date:9/17/2014)... As kinship care continues to be a primary ... their parents, emphasis on kinship care policy, practice, and ... supports for kinship caregivers and families. The Child ... is being held this week in Louisiana to highlight ... and service development for kinship caregivers, and identifies areas ...
(Date:9/17/2014)... been reserved for the very healthy. Astronauts are ... physical and psychological standards to prepare them for ... commercial spaceflight, average people can now fly for ... little information about what medical conditions or diseases ... environment, as most medical conditions have never been ...
Breaking Medicine News(10 mins):Health News:2014 Empire Waist Evening Dress Collection Now Unveiled At UWDress.com 2Health News:Elegant Petite Evening Dresses Introduced By Renowned Supplier iFitDress.com 2Health News:ADVOCATE Wins Radiology Billing Agreements with Fort Wayne Radiology 2Health News:ADVOCATE Wins Radiology Billing Agreements with Fort Wayne Radiology 3Health News:Arizona’s Children Association Kinship Service Providers Invited to Present at the CWLA National Conference 2Health News:Space: The final frontier… open to the public 2
... , , , , ... Month by enhancing the support services already available to its group life ... affected by the loss of a loved one - The Healing ... (written by Ellen Sabin and published by Watering Can Press). , ...
... young children , FRIDAY, Sept. 4 (HealthDay News) -- Since ... for complications from the H1N1 swine flu, U.S. health officials ... the virus in early childhood programs, such as day-care centers ... take the flu seriously, children less than 5 years old ...
... , , LOS ANGELES, Sept. 4 ... health insurance , Healthcare Reform is a TOP PRIORITY for the County,s working ... , On what is the eve of Congress, return to ... a creative approach to learn more about the importance of healthcare reform and ...
... PARK, Ill., Sept. 4 For the fourth consecutive year, Abbott (NYSE: ... Launch a Career" by BusinessWeek magazine. The list highlights companies ... Abbott moved up to No. 13, and was once again the top-ranked health ... every year since BusinessWeek initiated the list in 2006. , ...
... should be as safe as that for seasonal flu, officials ... public concern that H1N1 vaccines being tested might have unforeseen ... the shots seem safe. , "There have been no red ... National Institute of Allergy and Infectious Diseases, told HealthDay ...
... NEW HAVEN, Conn., Sept. 4 Rib-X Pharmaceuticals, Inc., a ... novel antibiotics for the treatment of acute care antibiotic-resistant infections, ... as Chief Business Officer. In his new role, Mr. Kassberg ... Mr. Kassberg, age 49, joins Rib-X from Proteolix, ...
Cached Medicine News:Health News:Anthem Life Offers The Healing Book to Help Young Life Insurance Beneficiaries Cope with Losing a Loved One 2Health News:U.S. Issues Swine Flu Guidelines for Day-Care Programs 2Health News:U.S. Issues Swine Flu Guidelines for Day-Care Programs 3Health News:Labor Day Event to Offer Angelenos Unique Opportunity to Learn About Healthcare Reform and Send a Strong Message to Washington D.C.! 2Health News:Abbott Again Named One of the 'Best Places to Launch a Career' by BusinessWeek 2Health News:Abbott Again Named One of the 'Best Places to Launch a Career' by BusinessWeek 3Health News:Swine Flu Vaccine Seems Safe: Experts 2Health News:Swine Flu Vaccine Seems Safe: Experts 3Health News:Rib-X Pharmaceuticals, Inc. Appoints Tom Kassberg Chief Business Officer 2
Sealing tape, white Rayon, breathable, NS...
Amplification Tape 96 featuring 3M adhesive technology. Good optical quality. Minimal autofluorescence. Certified RNase and DNase free....
Sealing tape featuring 3M adhesive technology. Compatible with DMSO. Good optical quality. Minimal autofluorescence....
Thermal Seal, Clear, Bulk...
Medicine Products: